The Definitive History of How Racism Built American Drug Prohibition

Harry Anslinger: The Man Who Criminalized Cannabis

Harry Jacob Anslinger became the first commissioner of the Federal Bureau of Narcotics in 1930. He would hold the position for 32 years — the longest tenure of any federal law enforcement chief in American history. When he took office, marijuana was essentially legal. When he left, it was the most feared drug in America.

The most important thing Musto established is that Anslinger's campaign was not a response to a genuine public health crisis. Marijuana was not causing mass insanity or widespread violence. Anslinger manufactured the crisis because his agency needed one.

The Racist Foundation

The racial framing followed a pattern Musto identified across American drug policy: each wave of drug prohibition was associated with a feared ethnic minority. Opium was linked to Chinese immigrants. Cocaine was linked to Black Americans in the South. Marijuana was linked to Mexican immigrants in the Southwest and Black jazz musicians in cities. The pharmacology was incidental. The prejudice was structural.

The AMA Fought Back — and Lost

The AMA's opposition deserves to be remembered because it demonstrates how thoroughly politics overrode science. Dr. William C. Woodward, the AMA's legislative counsel, was the only medical expert to testify against the Marihuana Tax Act. He told the House Ways and Means Committee that the Bureau's claims about marijuana-induced violence and insanity were unsupported. He argued that the proposed law would burden physicians and pharmacists and interfere with medical research.

The Committee's response was hostile. After Woodward's testimony, a committee member reportedly responded: "If you want to advise us on legislation, you ought to come here with some constructive proposals rather than criticism, rather than trying to throw obstacles in the way of something that the Federal Government is trying to do."

The Act passed. The AMA was ignored. Eighty-eight years later, cannabis remains in Schedule I.

Why This History Matters Now

Every feature of the current cannabis policy landscape traces back to decisions Musto documented:

David Musto: The Historian as Public Intellectual

David Franklin Musto (1936-2010) was uniquely positioned to write this history. He held both an MD from the University of Washington and a master's in History of Science from Yale. As Professor of Child Psychiatry and the History of Medicine at Yale School of Medicine, he bridged the gap between clinical understanding of substances and historical understanding of how societies regulate them.

In 1978, President Jimmy Carter appointed Musto to the White House Strategy Council on Drug Abuse — making him one of the rare academic historians to directly advise on the policy he studied. His cyclical theory of drug policy — that American society alternates between periods of tolerance and periods of prohibition, driven more by cultural anxiety than pharmacological evidence — has been cited by reformers and prohibitionists alike, though the implications tend to favor reform.

Musto died in October 2010 in Shanghai, where he was donating his papers to Shanghai University for a new Center for International Drug Control Policy Studies. He did not live to see the legalization wave that began two years later — but his work predicted it.

The Cyclical Pattern

The cyclical theory is both hopeful and cautionary. It suggests that legalization will likely continue to expand — but also that a future backlash is possible if public anxiety about cannabis (perhaps related to youth use, potency, or mental health effects) builds to a critical threshold. Understanding the cycle doesn't break it, but it does provide the historical literacy to recognize when political forces are manipulating drug policy for purposes unrelated to public health.